Breast cancer risk and methylenetetrahydrofolate reductase polymorphism.
- 1 February 2003
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 77 (3) , 217-223
- https://doi.org/10.1023/a:1021843019755
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Gene-Environment Interactions in Renal Cell CarcinomaAmerican Journal of Epidemiology, 2001
- Association of the C677T polymorphism in the MTHFR gene with breast and/or ovarian cancer risk in Jewish womenEuropean Journal Of Cancer, 2000
- 5, 10-Methylenetetrahydrofolate Reductase Gene Variants and Congenital Anomalies: A HuGE ReviewAmerican Journal of Epidemiology, 2000
- Breast cancer, heterocyclic aromatic amines from meat and N-acetyltransferase 2 genotypeCarcinogenesis: Integrative Cancer Research, 2000
- Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adultsProceedings of the National Academy of Sciences, 1999
- Colorectal Cancer: Molecules and PopulationsJNCI Journal of the National Cancer Institute, 1999
- Germ line polymorphisms in cytochrome-P450 1A1 (C4887 CYP1A1) and methylenetetrahydrofolate reductase (MTHFR) genes and endometrial cancer susceptibilityCarcinogenesis: Integrative Cancer Research, 1997
- Loss of heterozygosity at the 5,10-methylenetetrahydrofolate reductase locus in human ovarian carcinomasBritish Journal of Cancer, 1997
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- A genetic model for colorectal tumorigenesisCell, 1990